Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04777149 · ClinicalTrials.gov registry record · NA

Random Noise Stimulation to Enhance Cortical Drive & Improve Hand Function

A NA study of Spinal Cord Injuries and Tetraplegia, sponsored by Shepherd Center, Atlanta GA.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT04777149: Completed NA study of Spinal Cord Injuries and Tetraplegia, sponsored by Shepherd Center, Atlanta GA.

NCT04777149 is a NA study of Spinal Cord Injuries and Tetraplegia that has completed, run by Shepherd Center, Atlanta GA. The registered enrollment target is 19 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04777149, a NA study of Spinal Cord Injuries and Tetraplegia, has completed, sponsored by Shepherd Center, Atlanta GA.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

Cervical spinal cord injury (SCI) results in hand and arm function impairments and decreased independence in performance of daily activities such as bathing, eating, dressing, writing, or typing. Recent approaches that involve the application of non-invasive brain stimulation have the potential to strengthen the remaining connections between the brain and the spinal cord for improved hand function. Combining brain stimulation with performing upper limb functional tasks may further increase the ability of individuals with tetraplegia to use their hands. The purpose of this study is to investigate if "random noise", a special type of brain stimulation that most people cannot feel, can be used to enhance upper limb function in individuals with spinal cord injury. Specifically, the investigators will examine if a combined treatment protocol of random noise and fine motor training results in greater improvements in motor and sensory hand function compared to fine motor training alone.

Primary Outcome

The communication between brain and spinal cord will be evaluated. Sensors that detect muscle activity will be placed over hand muscles. Pulses of stimulation will be applied to the head using a type of non-invasive brain stimulation called transcranial magnetic stimulation (TMS). The size of the muscle response will be recorded.

Interventions

  • OTHER transcranial Direct Current Stimulation (tDCS)
  • OTHER transcranial Random Noise Stimulation (tRNS)
  • OTHER sham-stimulation

Study Locations (1)

Georgia

  • Shepherd Center - Atlanta

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2021-04-12
Est. Completion 2022-08-10
Phase NA
Shepherd Center, Atlanta GA

17 total trials

What the finished NCT04777149 record still lists

NCT04777149 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (69% lower).

The record links to 3 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 3 interventions - of which transcranial Direct Current Stimulation (tDCS) is the first listed.

NCT04777149 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT04777149 about?

NCT04777149 is a clinical study titled "Random Noise Stimulation to Enhance Cortical Drive & Improve Hand Function". Cervical spinal cord injury (SCI) results in hand and arm function impairments and decreased independence in performance of daily activities such as bathing, eating, dressing, writing, or typing. Recent approaches that involve the application of non-invasive brain stimulation have the potential to s...

What is the current status of trial NCT04777149?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2021-04-12. Estimated completion is 2022-08-10.

What conditions does trial NCT04777149 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Tetraplegia, Cervical Spinal Cord Injury.

What interventions are being tested in trial NCT04777149?

The interventions under investigation include: transcranial Direct Current Stimulation (tDCS) (OTHER), transcranial Random Noise Stimulation (tRNS) (OTHER), sham-stimulation (OTHER).

Who is sponsoring clinical trial NCT04777149?

This trial is sponsored by Shepherd Center, Atlanta GA, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04777149 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04777149's enrollment target sits among peer trials

19 138th of 202 higher than 65 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT04777149, the US trial registry maintained by the National Library of Medicine. NCT04777149 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.